Cisplatin hela

WebJul 1, 2009 · To test our hypothesis, we employed HeLa Tet (tetracycline)-off cells, which we previously used to overexpress the native plaa gene [21], and determined their apoptotic responses to cisplatin. HeLa cells were chosen because cervical tumor is a cisplatin-responsive tumor, while cervical tissues express the plaa gene [31], and respond to ... WebThe chemotherapeutic agent cisplatin, which is a small-molecule platinum compound and was originally found to inhibit bacterial growth and later identified as an anticancer agent, appears to most effectively treat …

Phospholipase A2-activating protein (PLAA) enhances cisplatin …

WebApr 29, 2015 · Hypopharyngeal squamous cell carcinoma (HSCC) has the worst prognosis among head and neck cancers. Cisplatin (DDP)-based chemotherapy is an important part of multimodal treatments. However, resistance to DDP severely impairs the effectiveness of chemotherapy for HSCC. WebJul 2, 2024 · To ascertain this, we determined effect of PARP-1 inhibition on cisplatin cytotoxicity in HeLa and SiHa cell lines. Combination of cisplatin with PJ34, a phenanthridinone-derived PARP-1 inhibitor, augmented cisplatin toxicity in vitro by decreasing cell proliferation, enhancing cell cycle block and cell death, and decreasing … popup screen in html https://ironsmithdesign.com

Molecules Free Full-Text The Challenging Treatment of Cisplatin ...

WebCisplatin is a chemotherapy drug which is used to treat cancers including: sarcoma, small cell lung cancer, germ cell tumors, lymphoma, and ovarian cancer. While it is often … WebOct 1, 2024 · The present study using network pharmacology revealed that salicylic acid and cisplatin shared common genes related to apoptosis in cervical cancer. Salicylic acid … WebHeLa Kyoto cells were treated for 1 h with 0.2 μg/mL colcemid 48 h after exposure to cisplatin. Both undamaged and damaged GM08505 cells were treated with colcemid 72 h after the first transfection (where indicated, GM08505 cells were treated with 1 μM cisplatin for 24 h prior to colcemid treatment). sharon musson

Quantitative Proteomic and Interaction Network Analysis of …

Category:Biomolecules Free Full-Text Sequential Interferon β …

Tags:Cisplatin hela

Cisplatin hela

Biomolecules Free Full-Text Sequential Interferon β …

WebCisplatin combination drugs induce stronger effects on autophagy than either of the components does. Combination drug-induced autophagy inhibits the growth of HeLa cell in a dose-dependent manner and … WebMixed lineage leukemia 5 (MLL5) transactivates the expression of E6 and E7 oncogenes in cervical cancer cells. In this study, we utilized CRISPR/Cas9 system with the aim to target HPV-E6 and MLL5 to enhance apoptosis efficiency in HPV-18 positive

Cisplatin hela

Did you know?

WebFeb 28, 2024 · One of the main problems in chemotherapy using platinum drugs as anticancer agents is the resistance phenomenon. Synthesizing and evaluating valid alternative compounds is challenging. This review focuses on the last two years of progress in the studies of platinum (II)- and platinum (IV)-based anticancer complexes. In … WebCisplatin is a platinum chemotherapeutic used in a variety of malignancies. The antineoplastic activity occurs from DNA cross-links and adducts, in addition to the generation of superoxide radicals. Nephrotoxicity is the most well-known and potentially most clinically significant toxicity.

WebMay 26, 2011 · The cisplatin resistant cell line HeLa/CDDP was generated previously under exposure to a clinically relevant concentration of cisplatin (1 µM) and was found to … WebOct 28, 2024 · Although the concurrent use of a chemotherapeutic agent and radiotherapy improves survival in patients with locally advanced or recurrent cervical cancer, severe side effects related to chemotherapy are frequent and may result in …

WebFeb 16, 2024 · severe or ongoing nausea and vomiting; vision problems, pain behind your eyes; hearing problems, ringing in your ears; pain, redness, swelling, or skin changes … WebResults: HeLa and SiHa cells were more sensitive to cisplatin and oxaliplatin treatment than C33A cells. HeLa and SiHa cells had significantly lower NRF2 gene levels, NQO1 …

WebAug 21, 2024 · Effect of cisplatin on the proliferative activity and survival of cancer cells. ( A) Viable cell number for HeLa and HeLa-SypHer2 cells. ( B) Percentage of dead (trypan blue positive) cells....

WebFor IFNβ-cisplatin sequential treatment protocol (E), HeLa cells were treated with 100 ng/mL IFNβ for 24, 48, or 72 h, and then cells were replated in 96-well plates and treated … sharon mutual calendarWebNational Center for Biotechnology Information popup screen in powerappsWebFeb 1, 2015 · In cell proliferation experiments, HeLa cells were treated with either cisplatin or myricetin and methyl eugenol alone, or vehiclealone for 12, 24 and 48 h. For apoptosis assay, cells weretreated with cisplatin or myricetin and methyl eugenol either alone or combined, or vehicle alone for 48 h. popup screen in html variableWebJun 1, 2024 · IC90 of paclitaxel in HeLa Pac RB was increased from 69 pM, 440 pM, 2,561 pM and 10,337 pM on 0th, 1st, 2nd, 3rd and 4th months, respectively. Interestingly, the resistant cells were recovered to... sharon muthuWebFeb 10, 2024 · Cisplatin is one of the most effective chemotherapy drugs and is widely used in the treatment of cancer, including hepatocellular carcinoma (HCC) and … sharon music schoolWebIn vitro response to ionizing radiation (IR), cisplatin (cDDP), hyperthermia (HT) and PARP1-inhibition (PARP1- i) as single and combinational treatments in four cervical cancer cell lines (SiHa, HeLa, CaSki and C33A). ( A) Normalized colony formation after IR in combination with cDDP or ( B) with HT. sharon mutterWebIn order to assist in optimizing treatment, we applied 5-ALA/PDT in combination with low-dose cisplatin to evaluate cytotoxicity in Hela cells. Methods: Antiproliferative effects of 5-ALA/PDT and cisplatin, alone and in combination, were assessed using MTT assay. pop up screen room for deck